Cancer Letters

Article	Citations
Immunotherapy for glioma: Current management and future application	328
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs	292
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs	204
CircRNA in cancer: Fundamental mechanism and clinical potential	196
Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages	188
Clinical practice guidelines for the management of adult diffuse gliomas	179
Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression	168
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?	165
Resveratrol for cancer therapy: Challenges and future perspectives	157
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets	156
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects	136
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America	133
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis	119
Exosomes as potential sources of biomarkers in colorectal cancer	119
Long non-coding RNAs in the doxorubicin resistance of cancer cells	117
RETRACTED: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma	106
Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?	104
Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway	100
Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunities	98
Writers, readers and erasers of RNA modifications in cancer	97
Machine Learning in oncology: A clinical appraisal	96
Sonodynamic therapy-derived multimodal synergistic cancer therapy	94
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer	90
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics	87
Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: A review	86

HPV post-infection microenvironment and cervical cancer	86
Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling	84
Non-coding RNA in bladder cancer	84
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway	83
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?	83
Phospholipase A2 superfamily in cancer	82
Metabolic adaptation in hypoxia and cancer	81
Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection	81
Translation of noncoding RNAs and cancer	80
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma	80
Hypoxia-induced epithelial to mesenchymal transition in cancer	80
Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B	79
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity	79
CircRNAs in lung cancer - Biogenesis, function and clinical implication	79
LncRNAs in cancer: Regulatory and therapeutic implications	78
Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma	77
DNA damage response and resistance of cancer stem cells	76
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment	76
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack	76
APOBEC: A molecular driver in cervical cancer pathogenesis	75
Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell	73
The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models	73
Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis	71
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity	69
Epstein–Barr virus-associated gastric cancer: A distinct subtype	69
Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis	69
Translatable circRNAs and lncRNAs: Driving mechanisms and functions of their translation products	68
Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids	67
Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer	66
VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling	65
M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942	64
Exosome-mediated delivery of RNA and DNA for gene therapy	64
Imaging of intratumoral heterogeneity in high-grade glioma	62
Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs	62
Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis	61
Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis	61
KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma	61
MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C	60
Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells	60
NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma	60
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers	59
Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer	58
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy	58
Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4	58
Fibronectin regulates anoikis resistance via cell aggregate formation	57
Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGF-β1 positive feedback loop	57
Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma	56
CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer	56
Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway	55
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope	55

SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition	55
Cancer screening in China: The current status, challenges, and suggestions	55
LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4	55
Wnt signaling pathway in cancer immunotherapy	54
Reality CHEK: Understanding the biology and clinical potential of CHK1	53
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy	53
Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis	53
SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells	53
Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling	53
LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers	53
Non-matrigel scaffolds for organoid cultures	53
Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma	51
Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway	51
Hypoxia-mediated drug resistance in breast cancers	51
Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer	51
YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer	51
27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression	50
The double-edged sword of H19 lncRNA: Insights into cancer therapy	50
Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer	50
The treatment landscape of metastatic prostate cancer	50
Hypoxia-responsive nanoparticles for tumor-targeted drug delivery	49
UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation	49
Exosomes in hypoxia-induced remodeling of the tumor microenvironment	48
Metabolism and function of polyamines in cancer progression	48
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis	48
Celastrol in cancer therapy: Recent developments, challenges and prospects	48
NK cells-directed therapies target circulating tumor cells and metastasis	47
Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms	47
Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy	47
The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies	47
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer	47
Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis	47
Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer	47
RETRACTED: Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3	46
HNRNPC impedes m6A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma	45
Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine	45
Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies	45
Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma	45
Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance	45
T-cell-based immunotherapy in colorectal cancer	45
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer	44
Autophagy in the crosstalk between tumor and microenvironment	44
Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis	44
Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer	44
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma	43
CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling	43
Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer	43
Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells	43
The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer	43
IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma	43
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy	42
Sonodynamic therapy: Rapid progress and new opportunities for non-invasive tumor cell killing with sound	42
Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?	42
Gene fusion neoantigens: Emerging targets for cancer immunotherapy	42
Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition	41
Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application	41
p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma	41
Non-coding RNA in thyroid cancer - Functions and mechanisms	41
IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway	40
Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells	40
Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy	40
A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis	40
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway	40
SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer	40
Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma	40
GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers	40
Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-Smad2/3 signaling	39
APCCDC20-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma	39
Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer	39
Dissecting miRNA signature in colorectal cancer progression and metastasis	39
Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia	39
ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer	39
FGF21 in obesity and cancer: New insights	38
Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E	38
Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages	38
Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-XL and MCL-1 leads to rapid induction of intrinsic apoptosis	38
Circulating RNAs in prostate cancer patients	38
Hypoxia-driven intratumor heterogeneity and immune evasion	38
Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes	38
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells	37

Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect	37
Hypoxia and cancer related pathology	37
Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulators	37
Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors	37
Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers	37
Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth	37
TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer	37
Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib	37
Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240/microRNA-124-3p/STAT3/MICA axis	37
PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer	37
Non-coding RNAs in gastric cancer	36
The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?	36
Extracellular vesicle long non-coding RNAs and circular RNAs: Biology, functions and applications in cancer	36
Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer	36
Exosomal O-GlcNAc transferase from esophageal carcinoma stem cell promotes cancer immunosuppression through up-regulation of PD-1 in CD8+ T cells	36
MicroRNA-15b in extracellular vesicles from arsenite-treated macrophages promotes the progression of hepatocellular carcinomas by blocking the LATS1-mediated Hippo pathway	36
TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells	36
Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer	36
Trials and tribulations of pancreatic cancer immunotherapy	36
HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer	35
Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles	35
Hypoxia and pancreatic ductal adenocarcinoma	35
HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma	35
FOXO3a in cancer drug resistance	35
Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)	34
Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma	34
The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance	34
Plasmacytoid dendritic cells recruited by HIF-1α/eADO/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma	34
LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling	34
Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis	34
Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer	34
AMPK-dependent phosphorylation of HDAC8 triggers PGM1 expression to promote lung cancer cell survival under glucose starvation	34
Organoid models in lung regeneration and cancer	33
Circular RNA TGFBR2 acts as a ceRNA to suppress nasopharyngeal carcinoma progression by sponging miR-107	33
Worldwide distribution, associated factors, and trends of gallbladder cancer: A global country-level analysis	33
Organoids to study immune functions, immunological diseases and immunotherapy	33
Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice	33
Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study	33
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models	33
Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system	33
Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy	33
Preclinical models for neuroblastoma: Advances and challenges	32
Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential	32
Colorectal cancer immunotherapy-Recent progress and future directions	32
miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA	32
Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor	32
Macrophages in pancreatic cancer: An immunometabolic perspective	32
Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation	32
miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer	32
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches	32
Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma	32
The evolving role of immune cells in prostate cancer	31
Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy	31
lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma	31
Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer	31
Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma	31
Prostate cancer dormancy and recurrence	31
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence	31
Functional long non-coding RNAs in hepatocellular carcinoma	31
Gut microbiota: A new piece in understanding hepatocarcinogenesis	31
Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner	31
IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells	31
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma	31
hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer	31
Exosome-mediated remodeling of the tumor microenvironment: From local to distant intercellular communication	31
The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome	31
Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing	31
HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway	31
DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo	30
Arginine deprivation as a strategy for cancer therapy: An insight into drug design and drug combination	30
Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis	30
Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies	30
Metabolic alterations in the tumor microenvironment and their role in oncogenesis	30
Direct targeting of HSP90 with daurisoline destabilizes β-catenin to suppress lung cancer tumorigenesis	30
Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells	30
Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling	30
Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3	30
Tumor microenvironment and metabolic remodeling in gemcitabine‐based chemoresistance of pancreatic cancer	30
Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo	30
Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges	30
Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis	30
METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation	30
Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications	29
Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma	29
TGF-β signaling networks in the tumor microenvironment	29
Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1	29
Understanding the cellular origin and progression of esophageal cancer using esophageal organoids	29
Intratumoral CD45+CD71+ erythroid cells induce immune tolerance and predict tumor recurrence in hepatocellular carcinoma	29
MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer	29
The human VRK1 chromatin kinase in cancer biology	28
Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer	28
Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression	28
A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening	28
Sex differences in health and disease: A review of biological sex differences relevant to cancer with a spotlight on glioma	28
Proprotein convertases: Key players in inflammation-related malignancies and metastasis	28